tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PPBT Stock Latest News

Purple Biotech Enters New ATM Agreement with H.C. Wainwright
Company AnnouncementsPurple Biotech Enters New ATM Agreement with H.C. Wainwright
10d ago
6K
PPBT
Purple Biotech Unveils Promising Cancer Treatment Developments in September 2025 Update
PremiumCompany Announcements
Purple Biotech Unveils Promising Cancer Treatment Developments in September 2025 Update
14d ago
6K
PPBT
Purple Biotech Secures European Patent for NT219 Combinations
PremiumCompany Announcements
Purple Biotech Secures European Patent for NT219 Combinations
20d ago
6K
PPBT
Purple Biotech receives intention to grant a European patent covering NT219
PremiumThe Fly
Purple Biotech receives intention to grant a European patent covering NT219
20d ago
PPBT
Purple Biotech Announces $18 Million Public Offering to Boost Oncology Pipeline
PremiumCompany Announcements
Purple Biotech Announces $18 Million Public Offering to Boost Oncology Pipeline
25d ago
6K
PPBT
Purple Biotech prices 5.99M ADSs at $1.00 in public offering
PremiumThe FlyPurple Biotech prices 5.99M ADSs at $1.00 in public offering
26d ago
PPBT
Purple Biotech Unveils Promising Data on CAPTN-3 Antibody Design
Premium
Company Announcements
Purple Biotech Unveils Promising Data on CAPTN-3 Antibody Design
26d ago
6K
PPBT
Purple Biotech announces new data on IM1240
Premium
The Fly
Purple Biotech announces new data on IM1240
26d ago
PPBT
Purple Biotech Expands CAPTN-3 Portfolio with Novel Antibody Targeting TROP2
PremiumCompany Announcements
Purple Biotech Expands CAPTN-3 Portfolio with Novel Antibody Targeting TROP2
27d ago
6K
PPBT
Purple Biotech expands CAPTN-3 portfolio with IM1305
PremiumThe Fly
Purple Biotech expands CAPTN-3 portfolio with IM1305
27d ago
PPBT
Purple Biotech files to sell 2.7M American Depositary Shares, warrants
PremiumThe Fly
Purple Biotech files to sell 2.7M American Depositary Shares, warrants
1M ago
PPBT
Purple Biotech Reports Q2 2025 Financial Results and Clinical Progress
PremiumCompany Announcements
Purple Biotech Reports Q2 2025 Financial Results and Clinical Progress
2M ago
6K
PPBT
Purple Biotech reports Q2 EPS 40c vs $1.80 last year
PremiumThe FlyPurple Biotech reports Q2 EPS 40c vs $1.80 last year
2M ago
PPBT
Purple Biotech Highlights Clinical Milestones and Pipeline Progress in H1 2025
Premium
Company Announcements
Purple Biotech Highlights Clinical Milestones and Pipeline Progress in H1 2025
2M ago
6K
PPBT
Purple Biotech issues letter to shareholders from CEO
Premium
The Fly
Purple Biotech issues letter to shareholders from CEO
2M ago
PPBT
Purple Biotech Unveils July 2025 Update on Cancer Drug Development
PremiumCompany Announcements
Purple Biotech Unveils July 2025 Update on Cancer Drug Development
3M ago
6K
PPBT
Purple Biotech Unveils CAPTN-3 Antibody Platform Advances at EACR 2025
PremiumCompany Announcements
Purple Biotech Unveils CAPTN-3 Antibody Platform Advances at EACR 2025
3M ago
6K
PPBT
Purple Biotech presents preclinical data on CAPTN-3 antibody platform
PremiumThe Fly
Purple Biotech presents preclinical data on CAPTN-3 antibody platform
3M ago
PPBT
Purple Biotech Initiates Phase 2 Study for NT219 in Head and Neck Cancer
PremiumCompany Announcements
Purple Biotech Initiates Phase 2 Study for NT219 in Head and Neck Cancer
3M ago
6K
PPBT
Purple Biotech announces initiation of Phase 2 study of NT219
PremiumThe FlyPurple Biotech announces initiation of Phase 2 study of NT219
3M ago
PPBT
Purple Biotech’s Clinical Advancements and Strategic Collaborations Highlight Promising Future
Premium
Ratings
Purple Biotech’s Clinical Advancements and Strategic Collaborations Highlight Promising Future
4M ago
PPBT
Purple Biotech Reports Q1 2025 Financial Results and Advances Clinical Programs
Premium
Company Announcements
Purple Biotech Reports Q1 2025 Financial Results and Advances Clinical Programs
4M ago
6K
PPBT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >